# Quest Diagnostics Inc (DGX) FY2026 Q2 P&L / Income Statement

- Company: Quest Diagnostics Inc (DGX)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-23, accession number 0001022079-26-000070
- Page: https://plicit.ai/financials/dgx/fy2026-q2-income-statement
- Chart image: https://plicit.ai/charts/dgx-fy2026-q2-income-statement-sankey.png

## Chart details: Revenue by Business Segment

Income statement for 2026-04-01 through 2026-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net revenues**: 3,043,000,000 US dollars
- **Cost of services**: 2,016,000,000 US dollars
- **Gross profit (calculated)**: 1,027,000,000 US dollars
- **Operating expenses (calculated)**: 568,000,000 US dollars
- **Operating income**: 459,000,000 US dollars
- **Total non-operating expense, net**: negative 47,000,000 US dollars
- **Income before income taxes and equity in earnings of equity method investees**: 412,000,000 US dollars
- **Income tax expense**: 88,000,000 US dollars
- **Net income**: 334,000,000 US dollars
- **DIS business**: 2,978,000,000 US dollars
- **All other operating segments**: 65,000,000 US dollars
- **Amortization of intangible assets**: 38,000,000 US dollars
- **Other operating expense (income), net**: 1,000,000 US dollars
- **Selling, general and administrative**: 529,000,000 US dollars
- **Equity in earnings of equity method investees, net of taxes**: 10,000,000 US dollars. Reported below-tax contribution to net income.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.
- Of which attributable to Quest Diagnostics Inc: $320.00 M; to noncontrolling interests: $14.00 M.